Milan, Italy

Francesco Mantegazza

This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Xenios Ag. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francesco Mantegazza. Retrieved from https://idiyas.com/inventor/francesco-mantegazza

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Francesco Mantegazza: Innovator in Extracorporeal Circulation Systems

Introduction

Francesco Mantegazza is a notable inventor based in Milan, Italy. He has made significant contributions to the field of medical technology, particularly in the development of extracorporeal circulation systems. With a total of 2 patents to his name, Mantegazza's work focuses on improving patient care through innovative solutions.

Latest Patents

Mantegazza's latest patents include a "Regional Ant-coagulation System for an Extracorporeal Circulation Circuit." This invention addresses the need for effective blood coagulation management during extracorporeal procedures. The system comprises a line for taking blood from the patient, a first filtering unit, and a line for returning the blood, defining a main circuit. Additionally, it features a secondary circuit for the recirculation of plasma water.

Another significant patent is the "Extracorporeal Circuit for CO Removal from Blood." This invention involves a circuit designed to remove carbon dioxide from the blood. It includes a line for taking blood from the patient, a decarboxylation assembly, and a line for returning the blood. The decarboxylation assembly consists of a first filtering unit, an oxygenator, and an electrodialyzer that generates both an acid solution and a basic solution.

Career Highlights

Francesco Mantegazza is currently associated with Xenios AG, a company that specializes in advanced medical technologies. His work at Xenios AG has allowed him to focus on developing innovative solutions that enhance patient outcomes in critical care settings.

Collaborations

Mantegazza has collaborated with notable colleagues such as Antonio Maria Pesenti and Alberto Zanella. These collaborations have contributed to the advancement of medical technologies and the successful development of his patents.

Conclusion

Francesco Mantegazza is a distinguished inventor whose work in extracorporeal circulation systems has the potential to significantly impact patient care. His innovative patents reflect his commitment to improving medical technology and enhancing the quality of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…